Bitoca, Faustina A.
HRN: 18-73-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2024
CEFTAZIDIME 1GM (VIAL)
09/22/2024
09/29/2024
IV
1g
Q8H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes